Published summary: 2026-03-07
Where the evidence converges
A specific AKT1 gene variant determined whether THC impaired psychomotor control, with carriers showing increased errors and reduced brain activation in a motor control region
Strong evidence · 1 studies
The sample consisted of healthy occasional users and may not represent heavy or dependent users. The authors noted these results require independent replication. Oral THC administration differs from s
Comprehensive review documenting reliable THC self-administration in monkeys and major cannabinoid-opioid-dopamine interactions underlying reward and dependence
Moderate evidence · 5 studies
Based on limited number of strong-evidence studies.
Where questions remain
A 1992 review found that despite widespread human use, animals would not self-administer THC and evidence of brain reward pathway stimulation was minimal
Moderate evidence · 15 studies
Published at the very beginning of the cannabinoid receptor era. Many of the puzzles identified were later resolved by endocannabinoid system research. The review's characterization of limited reward
A major review found THC caused cell death in the hippocampus, produced persistent cognitive deficits, and activated the same dopamine reward pathways as morphine, alcohol, and nicotine
Moderate evidence · 15 studies
The hippocampal cell death findings were from animal studies with high-dose exposure and have been debated in subsequent research. The review's characterization of cannabis toxicity as "underestimated
Adolescent but not adult cannabinoid exposure in rats produced lasting cross-tolerance to morphine, cocaine, and amphetamine in dopamine reward neurons, suggesting unique adolescent brain vulnerability
Moderate evidence · 15 studies
Animal models may not directly translate to human experience. The synthetic cannabinoid used (WIN55212.2) is more potent than THC. Only 3 days of treatment were used, which is very brief. The 2-week w
A literature review described cannabis addiction as a chronic brain disease involving dopamine and serotonin pathways, with chronic use producing lasting effects on cognitive and reward brain circuits
Moderate evidence · 15 studies
The review presented a somewhat one-sided view emphasizing negative effects. The Nigerian context may have influenced the framing, as cannabis policy and attitudes vary greatly by region. The literatu
Research gaps
- No meta-analyses have been published on this specific topic, limiting the ability to draw pooled quantitative conclusions.
- Long-term prospective studies tracking outcomes over 5+ years are largely absent from the literature.
- Research on diverse populations (different ages, ethnicities, and medical backgrounds) remains limited.
Key studies
A specific gene variant determined who lost motor control after THC
People respond very differently to cannabis, and understanding why has been a persistent question. This study identified a specific genetic mechanism: a variant in a dopamine-related gene that determines whether THC impairs the brain region responsible for stopping inappropriate actions.
How Alcohol Changes Your Endocannabinoid Levels and What That Means for How Drunk You Feel
This is the first evidence that endocannabinoids may explain individual differences in how people experience alcohol's rewarding effects. People whose 2-AG drops more after drinking may find alcohol less pleasurable, potentially influencing their drinking patterns.
Adolescents and adults showed different brain reward responses to cannabis in a controlled fMRI experiment
The developing adolescent brain may process cannabis differently than the adult brain. Understanding these age-dependent effects on reward circuits is critical for assessing the unique risks cannabis poses to younger users.
A comprehensive review of human brain imaging reveals how cannabis affects executive function, emotion, memory, and reward
This is the most comprehensive neuroimaging review of cannabis effects available, synthesizing evidence across multiple brain systems and imaging modalities to create a unified picture of how cannabis affects the human brain.
THC boosted brain activity in attention networks, and a common gene variant influenced the effect
This study identifies a specific gene (COMT) that influences individual vulnerability to acute THC effects, providing a biological basis for why cannabis affects people differently. The COMT gene is already known to influence prefrontal dopamine levels.
THC disrupted brain connectivity by boosting striatal glutamate and dopamine in occasional users
This is one of the first human studies to show the neurochemical cascade through which THC produces its subjective and cognitive effects: THC boosts glutamate, which enhances dopamine, which disconnects reward circuits from cortical control.
How the research developed
Pre-2000
3 studies published. Predominantly observational and review studies.
2000–2009
7 studies published. Includes 1 RCTs, 1 strong-evidence studies.
2010–2014
16 studies published. Includes 1 RCTs, 1 strong-evidence studies.
2015–2019
41 studies published. Includes 6 RCTs, 2 strong-evidence studies.
2020–present
62 studies published. Includes 3 RCTs, 1 strong-evidence studies.
How this summary was assembled
This consensus synthesizes 129 peer-reviewed studies: 11 randomized controlled trials (9%), 18 observational studies (14%), 25 reviews (19%), 2 case studies (2%), 73 other study types (57%). Studies span from the earliest available research through 2025. Evidence strength ratings reflect study design, sample size, and replication across multiple research groups.
These counts describe the source summary at publication. They may differ from the current library.